Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The First Low Molecular Weight Antibiotic from Lactic Acid Bacteria: Reutericyclin, a New Tetramic Acid

4 Aug 2000

Abstract excerpt

The first chemical proof is available to show that lactic acid bacteria, generally known for their limited metabolite spectrum, are able to produce antibiotics with a broad inhibitory spectrum. The new tetramic acid, reutericyclin (1), opens a new dimension in the discussion regarding the application of lactic acid bacteria in food preservation or for positively influencing the human intestinal microflora.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microbial Metabolic Engineering and Bioproduction
Share to Microbial Natural Products and Biosynthesis
Share to Probiotics and Fermented Foods

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10934421
DOI: 10.1002/1521-3773(20000804)39:15<2766::aid-anie2766>3.0.co;2-g

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

The First Low Molecular Weight Antibiotic from Lactic Acid Bacteria: Reutericyclin, a New Tetramic AcidPMID 10934421Read ↗

Elimination of highly multidrug-resistant wound bacteria by the lactic acid bacterial drug candidate ILP100Semantic proximity Read ↗

Lactic acid properties, applications and production: A reviewSemantic proximity Read ↗

Equisetin, reutericyclin and streptolodygin as natural product lead structures for novel antibiotic libraries.Semantic proximity Read ↗

State of the Globe: Doxycycline - An Old Wine in a New Bottle for Gram-Negative SepsisSemantic proximity Read ↗

Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlightsSemantic proximity Read ↗

One ring to rule them all: Current trends in combating bacterial resistance to the β‐lactamsSemantic proximity Read ↗

Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria.Semantic proximity Read ↗

In Silico/In Vitro Strategies Leading to the Discovery of New Nonribosomal Peptide and Polyketide Antibiotics Active against Human PathogensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.